Clinical Trial Update: Ofatumumab-based Induction Chemoimmunotherapy in Previously Untreated Patients With CLL/SLL [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ofatumumab-based induction chemoimmunotherapy in previously untreated chronic lymphocytic leukemia/small lymphocytic lymphoma patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Ofatumumab (ofatumumab)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Small Lymphocytic Lymphoma, CLL (Chronic Lymphocytic Leukemia) | Phase 2 | Status: COMPLETED | Results posted: 2019-09-17